Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Amgen Inc (AMGN)

Amgen Inc (AMGN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Amgen Inc ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320 USA

P: 805-447-1000 F: 805-447-1010

Description:

Amgen Inc. discovers, develops and delivers innovative human therapeutics. A biotechnology pioneer, Amgen was one of the first companies to realize the new science's promise by bringing safe and effective medicines from lab, to manufacturing plant, to patient. Amgen therapeutics have changed the practice of medicine, helping millions of people around the world in the fight against cancer, kidney disease, rheumatoid arthritis, and other serious illnesses. With a deep and broad pipeline of potential new medicines, Amgen remains committed to advancing science to dramatically improve people's lives.

Key Statistics

Overview:

Market Capitalization, $K 107,281,640
Shares Outstanding, K 609,936
Annual Sales, $ 23,747 M
Annual Net Income, $ 8,394 M
Last Quarter Sales, $ 5,557 M
Last Quarter Net Income, $ 1,992 M
60-Month Beta 1.16
% of Insider Shareholders 0.25%
% of Institutional Shareholders 77.26%
Float, K 608,411
% Float 99.75%

Growth:

1-Year Return -7.35%
3-Year Return 2.24%
5-Year Return 40.10%
5-Year Revenue Growth 27.15%
5-Year Earnings Growth 90.22%
5-Year Dividend Growth 180.85%

Per-Share Information:

Most Recent Earnings 3.56 on 04/30/19
Next Earnings Date 07/30/19
Earnings Per Share ttm 14.50
EPS Growth vs. Prev Qtr 4.09%
EPS Growth vs. Prev Year 2.59%
Annual Dividend Rate, $ 5.80
Annual Dividend Yield 3.25%
Most Recent Dividend 1.450 on 05/16/19
Next Ex-Dividends Date 05/16/19
Dividend Payable Date 06/07/19
Dividend Payout Ratio 36.64
Most Recent Split 2-1 on 11/22/99

AMGN Ratios

Ratio
Price/Earnings ttm 12.30
Price/Earnings forward 14.80
Price/Earnings to Growth 2.19
Return-on-Equity (After Tax) 71.02
Return-on-Assets (Before Tax) 14.07
Profit Margin % 35.35
Net Margin % 29.71
Debt/Equity 2.71
Price/Sales 4.58
Price/Cash Flow 9.87
Price/Book 10.11
Book Value/Share 17.76
Interest Coverage 7.86

AMGN Dividends

Date Value
05/16/19 $1.4500
02/14/19 $1.4500
11/15/18 $1.3200
08/16/18 $1.3200
05/16/18 $1.3200
02/14/18 $1.3200
11/16/17 $1.1500
08/15/17 $1.1500
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar